Package 0904-7264-61

{"route": ["ORAL"], "spl_id": "55b0fa69-7b11-49df-972a-e1d39b35b322", "openfda": {"nui": ["N0000175753", "N0000008486"], "unii": ["VZI5B1W380"], "rxcui": ["312136", "312137", "312138"], "spl_set_id": ["b1d54def-057d-4608-bc8f-1d967ac3ec91"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Major Pharmaceuticals"]}, "finished": true, "packaging": [{"sample": false, "description": "100 BLISTER PACK in 1 CARTON (0904-7264-61)  / 1 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "0904-7264-61", "marketing_end_date": "20270228", "marketing_start_date": "20221107"}], "brand_name": "OXCARBAZEPINE", "product_id": "0904-7264_55b0fa69-7b11-49df-972a-e1d39b35b322", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "0904-7264", "generic_name": "OXCARBAZEPINE", "labeler_name": "Major Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "OXCARBAZEPINE", "active_ingredients": [{"name": "OXCARBAZEPINE", "strength": "600 mg/1"}], "application_number": "ANDA078069", "marketing_category": "ANDA", "marketing_end_date": "20270228", "marketing_start_date": "20221107"}